Dr. Keith W Pratz M.D.
Hematologist-Oncologist | Hematology & Oncology
1650 Orleans St Crb I Room 186 Baltimore MD, 21231About
Dr. Keith Pratz is a hematologist oncologist practicing in Baltimore, MD. Dr. Pratz specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of Medicine And Dentistry of New Jersey / Robert Wood Johns 2002
University of Medicine And Dentistry of New Jersey / Robert Wood Johnson Med 2002
Provider Details
Expert Publications
Data provided by the National Library of Medicine- AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).
- FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML.
- Bench to bedside targeting of FLT3 in acute leukemia.
- Plasma protein binding of sorafenib, a multi kinase inhibitor: in vitro and in cancer patients.
- Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.
- Will FLT3 inhibitors fulfill their promise in acute meyloid leukemia?
- Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant.
- How I treat FLT3-mutated AML.
- Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression.
- Acute myeloid leukemia in the elderly: therapeutic options and choice.
- Role of Alternative Donor Allogeneic Transplants in the Therapy of Acute Myeloid Leukemia.
- Exposure-Response of Veliparib to Inform Phase II Trial Design in Refractory or Relapsed Patients with Hematological Malignancies.
- Phase 1 Study of Quizartinib in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia.
Dr. Keith W Pratz M.D.'s Practice location
PHILADELPHIA, PA 19104Get Direction
Dr. Keith W Pratz M.D.'s reviews
Write ReviewRecommended Articles
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Teen Treated for Lymphoma to Play College Baseball
Whether it’s the Dodgers or the Red Sox or the local high school team, they’re called ‘the boys of summer’.While summer is when the teams begin competitive play, they are very much the boys of spring as well.The temperature might be cool, but the air is sweet with promise.The players pull...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
Nearby Providers
- Dr. David Peter Cosgrove M.D.401 N. Broadway Baltimore MD 21231
- Dr. Akil Abid Merchant M.D.1650 Orleans St Baltimore MD 21231
- Dr. Amir T Fathi M.D.401 North Broadway Baltimore MD 21231
- Dr. Patrick Forde M.D.401 North Broadway Baltimore MD 21231
- Dr. Shanthi Marur MD1650 Orleans St Baltimore MD 21231
- Dr. Daniel Kejzman MD1650 Orleans Street Baltimore MD 21231